| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
AN2 Therapeutics, Inc.
13G
ANTX · 037326105
|
9.3% |
6/4/2025
Event 5/28/2025
|
||||
| Coastlands Capital LP | 9.3% | |||||
| Coastlands Capital Partners LP | 9.3% | |||||
| Coastlands Capital GP LLC | 9.3% | |||||
| Coastlands Capital LLC | 9.3% | |||||
| Matthew D. Perry | 9.3% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.